fbpx
QQQ
+ 0.00
349.89
+ 0%
DIA
+ 0.02
341.96
+ 0.01%
SPY
+ 0.03
425.07
+ 0.01%
TLT
+ 0.00
143.50
+ 0%
GLD
-0.01
166.05
-0.01%

Is Reddit Favorite BioNano Genomics About To Nosedive?

May 13, 2021 11:52 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Is Reddit Favorite BioNano Genomics About To Nosedive?

BioNano Genomics (NASDAQ:BNGO) is testing an important support at the $5 level. If this support breaks, shares could make a rapid and large move lower.

There’s an old saying on Wall Street that “gaps refill." It’s true and it could happen with BioNano.

When a stock makes a large move higher in a short period of time, little to no volume trades at the price levels the stock moves through. This type of action shows up on a chart as a gap. In December, BioNano gapped up from 50 cents to $5.

Support forms when remorseful sellers decide to buy their shares back after they trade at higher prices. Because of this, the more time that a stock trades at a certain level, the greater the amount of support that will form at it.

When stocks gap through levels, like BioNano did in December, they spend little to no time trading at them. Therefore, there isn’t sufficient time for meaningful support to form.

This is why when a stock gaps up through price levels, it could fall right back through them. There won’t be enough demand, or buyers, to provide support. It could happen with BioNano.

bngo.png

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

Bionano Runs Higher Following CCO Appointment

Bionano Genomics Inc. (NASDAQ: BNGO) shares climbed higher Monday after the company appointed Jason Priar as its Chief Commercial Officer. read more

Why BioNano Genomics Traded Higher Today

BioNano Genomics Inc (NASDAQ: BNGO) shares traded higher by 6.9% to $4.41 after the company reported better-than-expected first-quarter sales results. Bionano Genomics reported quarterly sales of $3.2 million, which beat the analyst consensus estimate of $2.9 million. read more

2 Biopharma Stocks That Look Ready For A Bullish Reversal

Ocugen Inc. (NASDAQ: OCGN) and Bionano Inc. (NASDAQ: BNGO) are two biopharma stocks moving higher Wedn read more